SCHEMBL3145741

SCHEMBL3145741

c1ccc(-c2nccnc2Nc2ccc(-c3cccnc3)cn2)nc1

nearest known ligand 0.51

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 4/20 0.51
NPC1 O15118 2/20 0.43
TP53 P04637 2/20 0.43
RAB9A P51151 2/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
TDP1 Q9NUW8 1/20 0.43
PIM1 P11309 1/20 0.43
PIM2 Q9P1W9 1/20 0.43
GPR55 Q9Y2T6 5/20 0.41
PKM P14618 1/20 0.41
TSHR P16473 1/20 0.41
ALDH1A1 P00352 1/20 0.39
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39
HIF1A Q16665 1/20 0.38
GRM5 P41594 1/20 0.38
DEGS1 O15121 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3142922 0.77 CYP2A6 (0.51) CYP2A6NPC1TP53RAB9ASMN1; SMN2
Hydrochloric Acid SCHEMBL3142386 0.76 CYP2A6 (0.50) CYP2A6NPC1TP53RAB9ASMN1; SMN2
SCHEMBL4902879 0.73 KARS1 (0.52) CYP2A6NPC1TP53RAB9ASMN1; SMN2
SCHEMBL28679939 0.71 CYP2A6 (0.68) CYP2A6NPC1TP53RAB9ASMN1; SMN2
SCHEMBL12068486 0.71 CYP2A6 (0.79) CYP2A6NPC1TP53RAB9ASMN1; SMN2
SCHEMBL3509967 0.71 CYP2A6 (0.85) CYP2A6NPC1TP53RAB9ASMN1; SMN2
SCHEMBL14297248 0.70 CYP2A6 (0.66) CYP2A6NPC1TP53RAB9ASMN1; SMN2
[2,3'']Bipyridinyl SCHEMBL998601 0.70 CYP2A6 (1.00) CYP2A6NPC1TP53RAB9ASMN1; SMN2
[2,3'']Bipyridinyl SCHEMBL29360744 0.70 CYP2A6 (1.00) CYP2A6NPC1TP53RAB9ASMN1; SMN2
[2,3'']Bipyridinyl SCHEMBL29486847 0.70 CYP2A6 (1.00) CYP2A6NPC1TP53RAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1742935-B1 POLYCYCLIC PYRAZINES AS POTASSIUM ION CHANNEL MODULATORS ICAGEN INC (US) 2010-02-24 EP claimed